参考文献
[1] Jemal A，et al.Global Cancer Atatistics. CA Cancer J Clin 2011，61：69-90.
[2] Johnson A，et al.Breast cancer incidence：what do the fiures mean？J Eval Clin Pract 2005，11(1)：27-31
[3] Quiet CA，et al.Natural history of node-negative breast cancer：a study of 826 patients with long-term follow-up.J Clin Oncol 2011，29(19)：2619-27.
[4] Giuliano AE，et al.Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.J Clin Oncol 2000，18[July(13)]：2553-9.
[5] A.Glechner，et al.Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer：A systematic review and meta-analysis. European Journal of Cancer 2013，49：812-825.
[6] Chen JJ，et al.Sentinel node biopsy and quality of life meansures in a Chinese population. Eur J Surg Oncol 2009，35[September(9)]：921-7.
[7] Lyman GH，et al.American Society of Clinical Ontology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early Stage Breast Cancer.J Clin Oncol，2005，23 (30)：7703-20.
[8] Reynolds C，et al.Sentinel lymph node biopsy with metastasis：can axillary dissection be avoided in avoided in some patients with breast cancer？J Clin Oncol 1999，17：1720-6.
[9] Bundred，N.J.et al.Is axillary lymph node clearance reuired in node-positive breast cancer？Nat.Rev.Clin.Oncol，2015，12：55-61.
[10] Hammond ME，et al.American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.J Clin Oncol.2010.28(16)：2784-95.
[11] Wolff AC，et al.Recommendations for human epidermal growth factor receptor 2 testing in breast cancer：American Society of Clinical Oncology/College Of American Pathologists clinical practice guideline update. J Clin Oncol.2013.31(31)：3997-4013.
[12] Wolff AC，et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for humen epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol.2007.25(1)：118-45., 百拇医药(薛世航 张同成 朱从伦 宋坚 陆振一)